The largest database of trusted experimental protocols
> Procedures > Diagnostic Procedure > Endoscopic Retrograde Cholangiopancreatography

Endoscopic Retrograde Cholangiopancreatography

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a minimally invasive procedure used to diagnose and treat conditions affecting the bile and pancreatic ducts.
During ERCP, a flexible endoscope is inserted through the mouth, down the esophagus, and into the small intestine, allowing access to the bile and pancreatic ducts.
This procedure enables the visualization, diagnosis, and treatment of various disorders, such as gallstones, bile duct strictures, and pancreatic diseases.
ERCP is a complex technique that requires specialized training and expertise to perform safely and effectively, with the potential for serious complications.
Optimizing ERCP protocols and techniques is crucial for enhancing medical research and improving patient outcomes.

Most cited protocols related to «Endoscopic Retrograde Cholangiopancreatography»

Between 1989 and 2012, 484 TP-IATs were performed at the University of Minnesota and University of Minnesota Amplatz Children’s Hospital. Of these, 75 were done in children and formed the study population. Our criteria for selection of patients with CP for TP-IAT has evolved over the years and have been standardized for the last 5 years.17 (link) Currently, to qualify for TP-IAT, the patient must have had abdominal pain of > 6 months duration with impaired quality of life e.g., inability to attend school, inability to participate in ordinary activities, repeated hospitalizations, or constant need for narcotics, each coupled with failure to respond to maximal medical treatment or endoscopic pancreatic duct drainage procedures. In addition, there must be objective findings of CP, including at least one of the following: (1) pancreas calcifications on CT scan, or abnormal ERCP, or ≥ 6/9 criteria on endoscopic ultrasound( EUS); or (2) any two of following three: (1) ductal or parenchymal abnormalities on secretin stimulated magnetic resonance cholangiopancreatography (MRCP), EUS of pancreas with 6/9 criteria positive, or abnormal pancreatic function tests with peak bicarbonate < 80 mmol/L).; or (2) Histopathologic confirmed diagnosis of chronic pancreatitis from previous operations; or (3) Hereditary pancreatitis (PRSS1 gene mutation, (SPINK1 gene mutation, CFTR gene mutations), with a compatible clinical history ; or (4) History of recurrent acute pancreatitis with > 3 episodes of pain associated with imaging diagnostic of acute pancreatitis and/or elevated serum amylase or lipase 3 times normal.17 (link)The current study was approved by the University of Minnesota Institutional Review Board. Informed consent and assent were obtained from parents and patients for all patients participating in quality of life assessments.
Publication 2014
Abdominal Pain Acidic Pancreatic Trypsin Inhibitor Bicarbonates Child Cholangiopancreatography, Magnetic Resonance Congenital Abnormality Cystic Fibrosis Transmembrane Conductance Regulator Diagnosis Drainage Endoscopic Retrograde Cholangiopancreatography Ethics Committees, Research Hereditary pancreatitis Hospitalization Hyperamylasemia Lipase Mutation Narcotics Pain Pancreas Pancreatic Duct Pancreatic Function Test Pancreatitis, Acute Parent Patients Physiologic Calcification PRSS1 protein, human Secretin Serum Surgical Endoscopy X-Ray Computed Tomography

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Abdomen Cholangiopancreatography, Magnetic Resonance Disease Progression Endoscopic Retrograde Cholangiopancreatography Ethics Committees, Research Genetic Predisposition to Disease Hereditary pancreatitis Pancreatic Diseases Pancreatitis Patients Physiologic Calcification Radionuclide Imaging Replicon X-Ray Computed Tomography
We hypothesised that the chronicity of pain (constant vs intermittent) rather than the severity (mild, moderate or severe) was a more significant determinant of QOL and resource utilisation in patients with painful CP. The aim of our study was to compare resource utilisation, disability and QOL among patients with CP who were experiencing differing types of abdominal pain, specifically mild to moderate pain versus severe pain and constant versus intermittent abdominal pain. Data for this study were derived from the North American Pancreatitis Study-2 (NAPS2).7 (link) NAPS2 was a multicentre prospective study conducted from 2000 to 2006 involving 20 centres across the USA which collected standardised data and blood from patients with acute recurrent pancreatitis and CP. Only data pertaining to patients with CP (n=540) were used for this analysis. CP was defined by predetermined imaging criteria (primarily endoscopic retrograde cholangiopancreatography (ERCP; note that ERCP was not required for eligibility and was not performed solely for the purpose of diagnosis or study enrolment) or CT) or histology. The detailed study protocol and methodology have been previously published.7 (link) The study was approved by the Institutional Review Board at each participating centre, and all subjects provided written informed consent prior to enrolment.
Publication 2011
Abdominal Pain BLOOD Chronic Pain Diagnosis Disabled Persons Eligibility Determination Endoscopic Retrograde Cholangiopancreatography Ethics Committees, Research North American People Pain Pancreatitis Pancreatitis, Chronic Patients

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2012
Abdomen Clinical Reasoning Congenital Abnormality Cyst Cytological Techniques Diagnosis Endoscopic Retrograde Cholangiopancreatography Gastroenterologist Hereditary pancreatitis Malignant Neoplasms Neoplasms, Mucinous Operative Surgical Procedures Pancreas Pancreatic Neoplasm Pathologists Patients Physicians Surgeons Vision
Between May 2000 and November 2006, 213 patients underwent a partial hepatectomy. Of all patients undergoing major liver resection (three or more Couinaud segments), both CT volumetry and HBS were preoperatively performed in 71 patients. Sixteen patients were excluded from the study because of preoperative PVE (n = 15) or partial portal vein thrombosis (n = 1) in the time period between HBS and CT volumetry. Hence, a group of 55 patients was retrospectively analyzed with the approval of our Institutional Review Board with waiver of informed consent. Table 1 summarizes the types of resection performed. Patients with a preoperative suspicion of hilar cholangiocarcinoma underwent an (extended) hemihepatectomy combined with hilar resection and caudate lobe resection. In cholestatic patients, preoperative biliary drainage was performed more than 6 weeks prior to surgery using endoscopic retrograde cholangiopancreatography or percutaneous transhepatic drainage.

Types of Liver Resection with the Corresponding Weight of the Resection Specimen

procedureNumber of patientsPercentageWeight resection specimen (g)
Extended right hemihepatectomy1425.5975 ± 247
Right hemihepatectomy2647.2936 ± 396
Extended left hemihepatectomy11.8443
Left hemihepatectomy1425.5348 ± 120
Total55100.0
Pre- and perioperative factors associated with postoperative morbidity and mortality were analyzed (Table 5). Histopathology of the resection specimen was assessed by an experienced pathologist taking into account features of cholestasis, steatosis, fibrosis, and chronic inflammation.
Postoperative complications were recorded according to the modified classification of surgical complications proposed by Dindo et al.18 (link) In-hospital complications were recorded as well as complications requiring hospital readmission within 3 months related to the operation. Minor complications included grade 1 and grade 2 complications. Major complications were defined as grade 3 and severe complications as grade 4 and grade 5 complications. Liver failure was defined as bilirubin plasma levels >50 µmol/l and/or prothrombin time index <50%,19 (link) elevated plasma ammonia levels combined with signs of hepatic encephalopathy and/or hepatorenal syndrome, requiring intensive care treatment.
Publication 2009
Ammonia Bile Bilirubin Cholestasis Drainage Endoscopic Retrograde Cholangiopancreatography Ethics Committees, Research Fibrosis Hepatectomy Hepatic Encephalopathy Hepatic Insufficiency Hepatorenal Syndrome Hospital Readmissions Inflammation Intensive Care Klatskin Tumor Pathologists Patients Plasma Postoperative Complications Steatohepatitis Times, Prothrombin Venous Thrombosis

Most recents protocols related to «Endoscopic Retrograde Cholangiopancreatography»

The study design was retrospective cohort study. The study proposal was approved by The Human Research Ethics Committee of Thammasat University (Medicine). The patients, who presented with symptomatic GS or complications of GS, then underwent LC since January 2017 to December 2021 in service of Hepato-Pancreato-Biliary and Transplantation unit in surgery department of Thammasat University Hospital, were considered to be enrolled into this study. The electronic medical record was thoroughly reviewed.
The important information including demographic data, clinical presentation, laboratory results, and radiological findings was collected. The operative time, intraoperative findings, perioperative complications, and conversion to open surgery were reviewed from operative notes. The laparoscopic procedure was carried out through three or four small incisions at umbilical and right upper quadrant areas. The operative time was counted from the opening of the first port-site incision to the closure of the last surgical wounds.
Some cases might be excluded because of the following reasons: (1) patients who underwent LC with other indication such as gallbladder polyp, (2) LC was performed in emergency setting for treatment of acute cholecystitis, and (3) there were any other procedures performed in the same setting of LC such as intraoperative ERCP. By the perioperative information, the patients were categorized into three groups by difficulty grading as given in Table 2.
The univariate analysis was performed using chi-square test for categorical data and Student's t-test for continuous data to define the significant factors affecting on very difficult LC and converted cases. Then multivariate analysis was carried out for both outcomes. Thereafter, the preoperative predictive scores of each patient were calculated using the original Randhawa scoring systems and also the modification of Tongyoo et al. The comparison between scores from both models was performed by many methods such as paired t-test, correlation coefficient, and area under receiver operating characteristic (ROC) curve. All of statistical analyses were performed by IBM SPSS® Statistics version 20 and their results were determined to be significant at P < .05.
Publication 2023
Acute Cholecystitis Conversion to Open Surgery Emergencies Endoscopic Retrograde Cholangiopancreatography Ethics Committees, Research Gallbladder Homo sapiens Laparoscopy Operative Surgical Procedures Patients Pharmaceutical Preparations Polyps Surgical Wound Transplantation Umbilicus X-Rays, Diagnostic

All procedures were performed using CO
2insufflation with the patient in prone or left lateral decubitus position under conscious sedation controlled by an anesthesiologist and a nurse. The study procedures were performed using a floor-mounted Siemens Artis zee multi-purpose (MP) fluoroscopy system (Siemens Healthcare, Erlangen, Germany) or a mobile Siemens Cios Alpha c-arm device (Siemens Healthcare, Erlangen, Germany). Fixed, mobile, and ceiling-mounted radiation shields and personal protective equipment, such as protective aprons, thyroid shields, and leaded eyewear were used during all the procedures. A more detailed description of the imaging protocols and radiation protection tools implemented is provided as supplementary material.
Other data collected for each procedure included patient characteristics (age, height, weight, and body mass index [BMI]), fluoroscopy time, KAP, and air-kerma at reference point (K
a,r). Moreover, the procedural complexity of each ERCP was determined and collected based on the 4-point American Society for Gastrointestinal Endoscopy (ASGE) complexity-grading system
18 (link)
19
. The radiation doses in ERCP and other gastrointestinal endoscopy procedures were compared. ERCPs performed for diagnosis and follow up of PSC included a significantly larger number of single image exposures compared to other ERCPs and were thus categorized separately. The effect of ERCP procedural complexity level and fluoroscopy system on radiation doses was then analyzed.
Publication 2023
Anesthesiologist Conscious Sedation Cranioosteoarthropathy Diagnosis Endoscopic Retrograde Cholangiopancreatography Endoscopy, Gastrointestinal Fluoroscopy Index, Body Mass Nurses Patients Radiation Protection Radiotherapy Surgical Procedures, Endoscopic Gastrointestinal Thyroid Gland

The data are presented as median (interquartile range [IQR], i. e., first quartile – third quartile). To compare categorical and continuous variables between patient characteristics, procedure types, fluoroscopy systems, ERCP procedural complexity levels, and interventionists, either Fisher’s Exact test or Mann-Whitney
U-test and Kruskal-Wallis test were used, respectively. All statistical tests were two-sided, and a
P < 0.05 was considered significant. Statistical analysis was performed with SPSS statistical software (IBM, Armonk, New York, United States, version 25.0).
Publication 2023
Endoscopic Retrograde Cholangiopancreatography Fluoroscopy Patients

This prospective observational study to determine occupational radiation doses was performed at the Helsinki University Hospital Endoscopy department between March 2021 and July 2021. The COVID-19 pandemic did not affect the number or type of performed procedures. Altogether 604 consecutive fluoroscopy-guided procedures to patients were included in the study. From these interventions, 560 were ERCPs and 44 were other gastrointestinal endoscopy procedures, such as duodenal stentings or dilatations of anastomotic strictures. Personal dose equivalents H
p(10), H
p(0.07), and H
p(3) for four gastrointestinal surgeons (S1-S4) and four gastroenterologists (G1-G4) and for assisting nurses (N_Zee and N_Cios) were measured using thermoluminescent dosimeters (TLD) and direct-ion storage dosimeters (DIS). Details of dosimetry practices and dose uncertainty estimation are provided as supplementary material. In the endoscopy department, ERCPs for diagnosis and follow up of primary sclerosing cholangitis (PSC) and dilatations and stentings for these patients are performed by gastroenterologists; surgeons perform all other ERCP procedures. Distributions of the performed and assisted procedures by endoscopist and assisting nurse are given in Table 1 s (supplementary materials). The study was approved by the Institutional Review Board and no patient informed consent was required.
Publication 2023
COVID 19 Cranioosteoarthropathy Diagnosis Dilatation Duodenum Endoscopic Retrograde Cholangiopancreatography Endoscopy, Gastrointestinal Ethics Committees, Research Fluoroscopy Gastroenterologist Nurses Patients Primary Sclerosing Cholangitis Radiometry Radiotherapy Stenosis Stents Surgeons Surgical Anastomoses Surgical Procedures, Endoscopic Gastrointestinal
PSC is progressive biliary fibrosis affecting intra and/or extrahepatic bile ducts[12 (link)] and diagnosed by laboratory tests [(cholestasis, Antineutrophil cytoplasmic antibodies (ANCA)], radiology [abdominal ultrasonography (US), abdominal computed tomography (CT), endoscopic retrograde cholangiopancreatography (ERCP), or magnetic resonance cholangiopancreatography (MRCP)], and liver biopsy. Primary biliary cholangitis (PBC) is characterized by the loss of small and medium-sized bile ducts on liver biopsy, elevated anti-mitochondrial antibodies, and altered gamma-glutamyl transferase and alkaline phosphatase (ALP) levels[13 (link)]. Non-alcoholic fatty liver disease (NAFLD) is characterized by fat storage in ≥ 5% of hepatic steatosis in the absence of concomitant liver disease (chronic viral hepatitis), use of steatosis-inducing medications (amiodarone or tamoxifen), autoimmune hepatitis, hemochromatosis, Wilson's disease, or excessive alcohol consumption[14 (link)]. Diagnosis of NAFLD was made by liver biopsies or US[15 (link)], and the severity score was previously stated[16 (link)]. Autoimmune hepatitis diagnosis based on the International Autoimmune Hepatitis Group criteria with a score of > 15 points consisting of demographic, histologic, and laboratory markers, including antinuclear antibodies with a titer of at least 1:40 and liver histology[17 (link)]. An aseptic liver abscess is diagnosed based on IBD history, US, and CT[18 (link)]. Ultrasound, colour Doppler, and/or CT scans were used to detect portal vein thrombosis.
Publication 2023
Abdomen Alkaline Phosphatase Amiodarone Anti-Antibodies Antibodies, Antinuclear Antineutrophil Cytoplasmic Antibodies Asepsis Autoimmune Chronic Hepatitis Bile Bile Ducts, Extrahepatic Biopsy Cholangiopancreatography, Magnetic Resonance Cholestasis Duct, Bile Endoscopic Retrograde Cholangiopancreatography Fatty Liver Fibrosis gamma-Glutamyl Transpeptidase Hemochromatosis Hepatic Duct Hepatitis, Chronic Hepatolenticular Degeneration Liver Liver Abscess Liver Diseases Mitochondria Non-alcoholic Fatty Liver Disease Pharmaceutical Preparations Primary Biliary Cholangitis Radiography Radionuclide Imaging Steatohepatitis Tamoxifen Thrombosis Ultrasonography Veins, Portal Venous Thrombosis X-Ray Computed Tomography

Top products related to «Endoscopic Retrograde Cholangiopancreatography»

Sourced in Japan
The TJF-260V is a video duodenoscope designed for diagnostic and therapeutic procedures in the upper gastrointestinal tract. It features a slim, flexible insertion tube and a wide, forward-viewing field of view.
Sourced in Japan
The JF-260V is a laboratory equipment product manufactured by Olympus. It is a high-quality instrument designed for precise and reliable measurements in various scientific and research applications. The core function of the JF-260V is to provide accurate and reproducible results for the user's specific needs. Further details on the intended use or specific features of the product are not available within the scope of this request.
Sourced in Japan
The TJF-240 is a medical imaging device designed for endoscopic procedures. It features a flexible insertion tube, a high-resolution video system, and a range of accessories to support various medical applications. The device's core function is to provide healthcare professionals with a tool for capturing and displaying high-quality images and videos during diagnostic and therapeutic procedures.
Sourced in Japan
The TJF-260 is a versatile video duodenoscope designed for endoscopic retrograde cholangiopancreatography (ERCP) procedures. It features a slim, flexible insertion tube and a distal end with a wide field of view to enable improved visualization of the papilla of Vater and the bile and pancreatic ducts.
Sourced in Japan, Germany
The VisiGlide2 is a lab equipment product from Olympus. It is a microscope slide intended for use in various scientific applications. The VisiGlide2 provides a clear and stable surface for samples under observation.
Sourced in Japan
The JF-260 is a compact, high-performance microscope designed for laboratory use. It features a sturdy construction and a range of optical capabilities to support various scientific applications.
Sourced in United States, Japan
Jagwire is a lab equipment product designed for use in various research and diagnostic applications. It serves as a versatile cable system capable of transmitting data, signals, or power between connected devices. The core function of Jagwire is to facilitate reliable and efficient connectivity within the lab environment.
Sourced in Japan
The JF-240 is a laboratory microscope designed for a variety of applications. It features high-quality optics, providing clear and detailed imaging. The microscope is equipped with various magnification levels to accommodate different sample types and observation needs.
Sourced in United States, Japan
Wallflex is a laboratory equipment product manufactured by Boston Scientific. It is designed to serve as a component in laboratory settings, providing a specialized function. The core function of Wallflex is to facilitate specific laboratory processes, though a detailed description cannot be provided while maintaining an unbiased and factual approach.
Sourced in Japan, United States
The VisiGlide is a lab equipment product designed to provide a clear and detailed view of microscopic samples. It features a high-quality optical system that delivers exceptional image quality and resolution. The VisiGlide is a versatile tool suitable for a wide range of laboratory applications.

More about "Endoscopic Retrograde Cholangiopancreatography"

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a minimally invasive diagnostic and therapeutic procedure used to examine and treat conditions affecting the bile and pancreatic ducts.
This complex procedure involves the insertion of a flexible endoscope, such as the TJF-260V, JF-260V, TJF-240, or TJF-260, through the mouth, down the esophagus, and into the small intestine, allowing access to the targeted ducts.
ERCP enables the visualization, diagnosis, and treatment of various disorders, including gallstones, bile duct strictures, and pancreatic diseases.
It is a crucial tool in the management of these conditions, often used in conjunction with other specialized devices like the VisiGlide2, JF-260, Jagwire, JF-240, or Wallflex.
Performing ERCP requires specialized training and expertise to ensure safe and effective execution, as the procedure carries the potential for serious complications.
Optimizing ERCP protocols and techniques, such as those found in the literature, pre-prints, and patents, is essential for enhancing medical research and improving patient outcomes.
PubCompare.ai is a powerful AI-driven platform that helps researchers and clinicians identify the most effective ERCP protocols and techniques, leveraging the latest advancements in artificial intelligence to inform and improve their medical practices.
By utilizing PubCompare.ai, you can discover the best ERCP approaches, enhance your research, and ultimately provide better care for your patients.